-
LivFul and Global Access Diagnostics announce partnership for COVID-19 test kit distribution
prnasia
June 09, 2021
LivFul and Global Access Diagnostics (GAD) today announced a new partnership to make a variety of diagnostic kits, starting with COVID-19 rapid antigen tests, available in Low to Middle Income Countries.
-
Ortho's VITROS® SARS-CoV-2 Antigen Test for High-Volume COVID-19 Testing Receives CE Mark; Allows for More Convenient Sample Collection and Expanded Viral Transport Media
prnasia
April 14, 2021
Ortho Clinical Diagnostics, one of the world's largest pure-play in vitro diagnostics companies, announced it received CE Marking for its VITROS® SARS-CoV-2 Antigen Test, initially launched in October 2020.
-
Roche announces the upcoming launch of the SARS-CoV-2 Rapid Antigen Test Nasal allowing for patient self-collection
worldpharmanews
February 07, 2021
Roche announced it has obtained the CE mark for its new SARS-CoV-2 Rapid Antigen Test Nasal. The test will be available in countries accepting the CE mark by mid-February 2021.
-
LumiraDx Receives SARS-CoV-2 Antigen Test Authorization in Japan and Brazil; Italy Recommends Expansion of Microfluidic Antigen Testing
prnasia
January 21, 2021
LumiraDx, the next-generation point-of-care diagnostic testing company, announced today multinational approvals of its SARS-CoV-2 Antigen Test.
-
ForaCare Suisse AG Releases Rapid COVID-19 Antigen Test
prnewswire
January 08, 2021
ForaCare Suisse AG announced the release of its antigen test, FORA COVID-19 Antigen Rapid Test, that provides fast, accurate and easy-to-interpret test results.
-
Mologic Receives CE Mark Approval for COVID-19 Rapid Antigen Test
americanpharmaceuticalreview
December 31, 2020
Mologic has announced its professional-use COVID-19 Rapid Antigen Test has been certified with a CE mark, following independent assessment by the Liverpool School of Tropical Medicine (LSTM).
-
Avacta Announces SARS-CoV-2 Rapid Antigen Test Update
americanpharmaceuticalreview
December 08, 2020
Avacta Group has announced progress in the development of a highly scalable manufacturing process for a lateral flow SARS-CoV-2 antigen test being carried out with BBI Solutions, and that the lateral flow test has very good analytical sensitivity with ...
-
Ortho Awarded BARDA Contract to Accelerate Antigen Test Development and Additional SARS-CoV-2 Antibody Test Milestones
prnasia
September 22, 2020
Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, today announced its continued collaboration with the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and...
-
Roche to launch SARS-CoV-2 rapid antigen test
pharmatimes
September 03, 2020
Roche is gearing up to launch an antigen test able to “reliably and quickly” triage people suspected of SARS-CoV-2, with results available in just 15 minutes.
-
Abbott's fast, $5, 15-minute, easy-to-use COVID-19 antigen test receives FDA Emergency Use Authorization
worldpharmanews
August 31, 2020
Abbott announced that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for its BinaxNOW™ COVID-19 Ag Card rapid test for detection of COVID-19 infection.